Related Experiment Video
Updated: Jan 23, 2026

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
Published on: August 25, 2019
Genetic testing in cardiomyopathies: do we need to redefine the UK national testing criteria?
Andrew Chisom Madu1, Anthony David Dimarco1,2, Amy Hardy-Wallace1
1Essex Cardiothoracic Centre, Basildon University Hospital, Basildon, UK.
Insights
A significant number of patients with inherited cardiomyopathy and a genetic cause did not meet UK testing criteria. Wider genetic testing (GT) guidelines, focusing on phenotype severity, could benefit at-risk relatives.
Area of Science:
- Cardiovascular Genetics
- Genomic Medicine
Background:
- Inherited cardiac conditions like dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) often have a monogenic cause.
- Genetic testing (GT) can identify pathogenic gene variants, impacting patient management and family screening.
- Current UK National Genomic Test Directory (NGTD) criteria for GT are restrictive, contrasting with broader European Society of Cardiology (ESC) recommendations.
Purpose of the Study:
- To determine the prevalence of pathogenic genotypes in patients with DCM or HCM who did not meet NGTD criteria for genetic testing.
- To evaluate the diagnostic yield of GT in this cohort and its implications for family members.
Main Methods:
- Retrospective analysis of 257 patients with confirmed DCM or HCM undergoing GT.
- Data collected from the Essex Inherited Cardiac Conditions Clinic between January 2023 and January 2025.
Main Results:
- The diagnostic yield of GT was 19.9% for DCM and 17.4% for HCM.
- 14.8% of gene-positive DCM patients and 14.3% of gene-positive HCM patients did not meet NGTD criteria, often due to age of onset.
- All DCM patients not meeting criteria showed myocardial fibrosis, suggesting phenotype severity is a key indicator.
Conclusions:
- Approximately 1 in 7 patients with cardiomyopathy and a pathogenic genotype fall outside current UK testing criteria.
- Adopting wider ESC guidelines, emphasizing phenotype severity (e.g., myocardial scarring) over strict age cut-offs, is recommended.
- Implementing broader GT criteria can facilitate predictive testing for an average of 4 at-risk first-degree relatives per identified patient.
Introduction:
Inherited cardiac conditions, including dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM), may have a monogenic cause identified through genetic testing (GT). Confirmation of pathogenic gene variants can have important implications for the patient and their relatives. The UK National Genomic Test Directory (NGTD) provides strict criteria on the indications for GT; however, the European Society of Cardiology (ESC) recommends wider GT. We reviewed the prevalence of pathogenic genotypes in patients undergoing GT who did not meet the NGTD criteria.
Methods:
We conducted a retrospective analysis of patients who underwent GT with a confirmed diagnosis of HCM or DCM attending the Essex Inherited Cardiac Conditions Clinic between January 2023 and January 2025.
Results:
257 patients were included in the analysis, with 136 patients with DCM (52.9%) and 121 patients with HCM (47.1%). The diagnostic yield of GT was 19.9% in DCM and 17.4% in HCM.14.8% of gene-positive patients with DCM and 14.3% of gene-positive patients with HCM did not meet current UK testing criteria, predominantly due to age of onset. All gene-positive patients in the DCM subgroup not meeting current NGTD criteria for testing had evidence of myocardial fibrosis.
Conclusion:
A significant minority of patients (1 in 7) with cardiomyopathy and a pathogenic genotype did not meet current UK testing criteria; each patient has an average of 4 first-degree relatives at risk who will benefit from predictive GT. We propose the adoption of the wider ESC guidance, removing the strict age-related cut-offs and being guided more by the severity of the phenotype, particularly involving myocardial scarring.
Related Concept Videos
Testes: Histology
The spermatogenic cells, responsible for producing sperm, are...
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Testes: Gross Anatomy
Each testis is surrounded by the tunica albuginea, a dense connective tissue layer that provides structural support and protection. This layer is covered by an outer serous membrane called the tunica vaginalis, which helps reduce friction...
Significance Testing: Overview
Testing Water Quality
Types of Hypothesis Testing
When the null and alternative hypotheses are stated, it is observed that the null hypothesis is a neutral statement against which the alternative hypothesis is tested. The alternative hypothesis is a claim that instead has a certain direction. If the null hypothesis claims that p = 0.5, the alternative hypothesis would be an opposing statement to this and can be put either p > 0.5, p < 0.5, or p...

